Clinical trial

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

NCT05276401

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention 5% Bisphosphocin Topical Gel Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Topical Gel Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 10% Bisphosphocin Topical Gel Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2022-03-11

PhasePHASE2

Conditions

Chronic Diabetic Foot Ulcersunresolved

Interventions

5% Bisphosphocin Topical GelDRUG

Placebo Topical GelDRUG

10% Bisphosphocin Topical GelDRUG

Sponsors & collaborators

Lakewood-Amedex Inclead sponsor

Professional Education and Research Institutecollaborator

PrimeVigilancecollaborator

Mapped research locations

RochesterNew York, United States1 FresnoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05276401 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.